Kite Pharma (KITE) Highlights Pre-Clinical Data on KITE-585, a Fully … – StreetInsider.com
|
Kite Pharma (KITE) Highlights Pre-Clinical Data on KITE-585, a Fully …
StreetInsider.com Kite Pharma, Inc. (NASDAQ: KITE) today announced new data presentations from preclinical studies related to KITE-585, a fully human anti-B cell maturation … |
